Zobrazeno 1 - 10 of 26 pro vyhledávání: '"T. B. Christensen"'
1
Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx®) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas
Autor: Sandrine Marreaud, Peter Reichardt, Daniel Pink, Søren Daugaard, T B Christensen, J.-Y. Blay, Ole S. Nielsen, M. van Glabbeke, Cédric Hermans, Ian Judson
Publikováno v: Nielsen, O S, Reichardt, P, Christensen, T B, Pink, D, Daugaard, S, Hermans, C, Marreaud, S, van Glabbeke, M, Blay, J & Judson, I 2006, ' Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas ', European Journal of Cancer, vol. 42, no. 14, pp. 2303-9 . https://doi.org/10.1016/j.ejca.2006.04.011
This phase I study evaluated the toxicity of first-line combined pegylated liposomal doxorubicin (Caelyx®) and ifosfamide in patients with advanced and/or metastatic soft tissue sarcomas. Five dose levels (L) were studied: Caelyx® 30 mg/m2 (L1–4)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0104d95fa57c977eda77fe238f6d6c1
https://doi.org/10.1016/j.ejca.2006.04.011
Zobrazit plný text záznamu
2
Validation of 125I-hCG as a marker for elimination of hCG and stability of 125I-hCG after in vivo injection in humans
Autor: F Engbaek, T B Christensen, Peter Berger, T Bacher, H. von der Maase, J Marqversen
Publikováno v: British Journal of Cancer
We have recently introduced 125I-hCG as an elimination marker in patients with human chorionic gonadotrophin (hCG) producing testicular cancer. 125I-hCG is a well-known reagent in clinical biochemistry and is used extensively in hCG assays. Previous
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a29703131ff3134768db288fe84ac52
https://doi.org/10.1038/sj.bjc.6690566
Zobrazit plný text záznamu
4
125I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer
Autor: T. B. Christensen, J Marqversen, H. von der Maase, F Engbaek, S I Nielsen, Claus Kamby
Publikováno v: British Journal of Cancer
The rate of reduction in the concentration of serum human chorionic gonadotrophin (hCG) following chemotherapy for germ cell tumours may follow a complex pattern, with longer apparent half-life during later stages of chemotherapy, even in patients tr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cff5148bad97c13965d864cdc16241fc
http://europepmc.org/articles/PMC2363107
Zobrazit plný text záznamu
6
Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group
Autor: Sandrine Marreaud, Ole S. Nielsen, Patrick Schöffski, Sebastian Bauer, Peter Reichardt, Joerg T. Hartmann, T B Christensen, Søren Daugaard, M. van Glabbeke, Daniel Pink, J.-Y. Blay
Publikováno v: Reichardt, P, Nielsen, O S, Bauer, S, Hartmann, J T, Schöffski, P, Christensen, T B, Pink, D, Daugaard, S, Marreaud, S, Van Glabbeke, M & Blay, J Y 2007, ' Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group. ', European Journal of Cancer, vol. 43, no. 6, pp. 1017-22 . https://doi.org/10.1016/j.ejca.2007.01.014
No standard treatment is established for patients with advanced soft tissue sarcoma after previous chemotherapy with anthracyclines and ifosfamide, given either in combination or sequentially. Exatecan (DX-8951f) is a totally synthetic analogue of th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::291d7281a1aec7507f35837fa76d7f42
https://pubmed.ncbi.nlm.nih.gov/17336054
Zobrazit plný text záznamu
7
Cardiac output measured by electric bioimpedance compared with the CO2 rebreathing technique at different exercise levels
Autor: T B, Christensen, B V, Jensen, J, Hjerpe, I L, Kanstrup
Publikováno v: Clinical physiology (Oxford, England). 20(2)
In the lower range of cardiac output (CO, up to 15 l min-1), we found an excellent agreement between CO measured by bioimpedance and carbon dioxide rebreathing techniques. CO estimated by bioimpedance was generally lower. The bioimpedance method had
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f919eb95539c78517790d93473008e31
https://pubmed.ncbi.nlm.nih.gov/10735976
Zobrazit plný text záznamu
8
[Sentinel node diagnostics in malignant melanoma]
Autor: A I, Eigtved, M L, Krag, K K, Dahlstrøm, B R, Juhl, T B, Christensen
Publikováno v: Ugeskrift for laeger. 161(16)
New trial have shown that immediate regional lymph node dissection offers increased survival in patients with regional lymph node metastases only. Introduction of isotope technique to identify the first node, the sentinel node (SN), receiving lymph f
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1bcf9a77334ec254d2b9c06500016421
https://pubmed.ncbi.nlm.nih.gov/10235044
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje